# | | Name | Source | Ver | Description |
1 | | Atc | hl7.org.nz.fhir.ig.formulary#current | R4B | Anatomical Therapeutic Chemical (ATC) Classification - see https://www.who.int/tools/atc-ddd-toolkit/atc-classification |
2 | | Cautionary and Advisory Label | hl7.org.nz.fhir.ig.formulary#current | R4B | Cautionary and Advisory Label |
3 | | Drug Product Manufacturing Batch | hl7.fhir.us.pq-cmc#current | R5 | This profile defines the details of a batch of medicine. |
4 | | Extension - Actual Yield dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
5 | | Extension - Actual Yield Unfiltered dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
6 | | Extension - Batch Designation dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
7 | | Extension - Batch Number of Vials dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
8 | | Extension - Batch Release Date dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
9 | | Extension - Batch Retest Date dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
10 | | Extension - Batch Substance Batch dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
11 | | Extension - Instance Comment dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
12 | | Extension - Manufacturing Process dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
13 | | Extension - Medication Definition dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
14 | | Extension - Packaging Date dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
15 | | Extension - Packaging Site dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
16 | | Extension - Table Footnote dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
17 | | Extension - Test Comment dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
18 | | Extension Target Fill Weight dx-PQ | hl7.fhir.uv.dx-pq#current | R5 | |
19 | | Extension UK Core Medication Trade Family | fhir.r4.ukcore.stu1#1.0.4 | R4 | This Extension is used to identify a Trade Family or brand associated with a Medication, in particular a Virtual Therapeutic Moiety (VTM). |
20 | | Funding | hl7.org.nz.fhir.ig.formulary#current | R4B | Core funding information specific to NZ. The extension can be added multiple times to a product for each PHARMAC schedule. These can be differentiated via the scheduleDate field. |
21 | | FundingRule | hl7.org.nz.fhir.ig.formulary#current | R4B | Funding restriction information which complements the general funding information provided in the nzf-funding extension. The extension can be added multiple times to a product for each given rule as well as for each PHARMAC schedule. These can be differentiated via the scheduleDate field. |
22 | | LegalClass | hl7.org.nz.fhir.ig.formulary#current | R4B | Legal classification |
23 | | Link | hl7.org.nz.fhir.ig.formulary#current | R4B | Reference to other information about this medication |
24 | | Medication Brand Name | hl7.fhir.au.base#current | R4 | This extension applies to the Medication, MedicationRequest, MedicationDispense amd MedicationStatement resources and is used to represent the brand name of a medication. This extension is not to be the sole representation of the medication concept; it shall not be used as a substitute for medication code (e.g. Medication.code or MedicationStatement.medicationCodeableConcept).
If a system can only supply branded product information in text form, that information will be supplied in the text portion of that code e.g. code.text or medicationCodeableConcept.text. This extension only supports the name portion of a medication concept, not the branded product or product pack information. It is available for use for where a system needs to separate out the brand name string for handling or other processing. |
25 | | Medication Generic Drug Name | hl7.fhir.au.base#current | R4 | This extension applies to the Medication, MedicationRequest, MedicationDispense and MedicationStatement resources and is used to represent the generic name of a medication. The generic medication text name may not be the same as the subject medication (prescribed, dispensed or stated) but may be used to provide an additional or equivalent drug name that is a generic medication concept. This extension is not to be the sole representation of the medication concept; it shall not be used as a substitute for medication code (e.g. Medication.code or MedicationStatement.medicationCodeableConcept).
If a system can only supply generic product information, and only in text form, that information will be supplied in the text portion of that code e.g. code.text or medicationCodeableConcept.text. This extension only supports the name portion of a medication concept, not the generic product or product pack information. It is available for use for where a system needs to separate out the generic name string for handling or other processing. |
26 | | Medication Manufacturing Batch | hl7.fhir.uv.extensions.r4#1.0.0 | R4 | The date at which the drug substance or drug product was manufactured. The specific operation/step in the process used to determine the date is specified by the manufacturingDateClassification element. |
27 | | Medication Strength | hl7.fhir.au.base#current | R4 | This extension applies to the Medication resource and is used to represent the strength of a medication as text. |
28 | | Medsafe | hl7.org.nz.fhir.ig.formulary#current | R4B | Medsafe package, reg situation and administration route details |
29 | | no-basis-prescriptiongroup | hl7.fhir.no.basis#2.1.2 | R4 | Part of norwegian standard for describing a prescription. |
30 | | NzmtDescription | hl7.org.nz.fhir.ig.formulary#current | R4B | Specific NZMT descriptions that apply to this medication |
31 | | NzmtType | hl7.org.nz.fhir.ig.formulary#current | R4B | The NZ Medicines Terminology (NZMT) Data Class – MP (Medicinal Product), MPUU (Medicinal Product Unit of Use), MPP (Medicinal Product Pack), TP (Trade Product), TPUU (Trade Product Unit of Use), TPP (Trade Product Pack) or CTPP (Containered Trade Product Pack) – that the Medication is a member of. |
32 | | PrescribeByBrand | hl7.org.nz.fhir.ig.formulary#current | R4B | True if can be prescribed by brand |
33 | | RelatedMedication | hl7.org.nz.fhir.ig.formulary#current | R4B | A related medication within the NZMT hierarchy |
34 | | SupplyInformation | hl7.org.nz.fhir.ig.formulary#current | R4B | Information around the supply and availability of medications applied at each NZMT level. For example, when paracetamol tablets are in short supply an alert may be attached to the MP level medication along with the relevant details. |
35 | | Unapproved | hl7.org.nz.fhir.ig.formulary#current | R4B | True if this medication has not been approved by Medsafe and can be prescribed under section 29 |